JAKARTA – As many as 1.2 million doses of vaccine Covid-19entered Indonesia on Sunday (6/12) night. The arrival of the Covid-19 vaccine made by Sinovac is considered to increase public confidence in investing in the capital market.
“Last night Covid-19 vaccine already landed in Indonesia. Hopes it will increase public confidence in investing in the capital Indonesia Market”. Said President Director of PT BRI Danareksa Friderica Widyasari Goddess, Monday (7/12).
Friderica admitted the Covid-19 pandemic had caused the domestic capital market index to fall sharply. Until it touched its lowest point at 3,900. However, conditions in the index began to improve with the launch of various programs for national economic recovery accompanied by efforts to develop vaccines.
As of today, the Composite Stock Price Index (IHSG) has successfully penetrated the 5,900 positions. During the first trading session, JCI consistently moved in the green zone as news of the entry of the Covid-19 vaccine made by Sinovac into Indonesia.
Sinovac Vaccine Makes Capital Market Optimistic
Friderica sees that capital market players tend to be optimistic in the midst of the Covid-19 pandemic. They Are driving by the improving prospects for Indonesia’s economy in the future.
It reflects this in a number of indicators, including an increase in average daily transactions and daily frequency of investors in the capital market.
Currently, the average daily transaction value of investors in the capital market has almost returned to pre-pandemic times. Prior to Covid-19, the daily transaction value was around IDR 9 trillion per day and decreased to IDR 7 trillion per day at the start of the pandemic. Now, the average transaction value of investors has risen back to Rp. 8.5 trillion per day.
Likewise, the average daily transaction frequency. According to Friderica, the increase in activity in the capital market has received encouragement from domestic investors. “This is a surprising phenomenon, namely the rise of retail domestic investors in the Indonesian capital market,” said Friderica.
The sentiment of the arrival of vaccines also uplifted a number of pharmaceutical listed stocks from China. PT Kimia Farma Tbk shares rose 12.68 percent at the close of the first session of the JCI Monday to a level of Rp 4,000 per share. Meanwhile, PT Indofarma Tbk recorded a 14.75 percent increase in shares today to a level of Rp 3,890 per share.
Also, read another news article here.